Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Development 147

pharmaphorum

SEPTEMBER 16, 2021

The decision by shareholders has been greeted with consternation by health charities, public health specialists and doctors organisations, which have mounted a campaign against placing a pharma company in the hands of a big tobacco group. — Sarah Woolnough (@swoolnough) September 16, 2021.

Scientist 90

Scientist Production Marketing Pharma Companies 90

pharmaphorum

JUNE 14, 2021

Delytact is an engineered herpes simplex virus type 1 (HSV-1) designed to selectively replicate in – and kill – tumour cells without affecting normal tissues, and was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo.

Clinical Trials 119

Clinical Trials Clinical Trials Trials Pharma Companies 119

pharmaphorum

APRIL 19, 2022

RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. The company recently raised $16.5 So] we are trying to go for the international market.”. “In I try to still have the attitude of a scientist,” he said. “We

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Marketing 105

Marketing Drugs Development Regulation 105

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen.

Pharma Companies 145

Pharma Companies Development Medicine Drugs 145

pharmaphorum

SEPTEMBER 29, 2020

The industry is asking itself how to stay innovative, how to develop and bring to market higher quality therapies to patients – and how to do this faster and more efficiently. A diversity of collaboration types. Case Study: From Technology Agreement to co-development and co-commercialisation partnership.

Research 132

Research Gene Editing Development Gene 132

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Reagent Pharma Companies Scientist 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

APRIL 1, 2021

There are a lot of scientists who want to better understand biology but don’t have the money to do it in wet settings. The tandem of AI and translational scientists can then find the strongest signals and figure out why those targets worked. “You So what do they do? They go into bioinformatics”. So, what do they do?

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

JUNE 10, 2022

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. However, pharma’s commercial leaders are uniquely positioned to drive the strategic digital shift in patient care journeys. Digital can help ensure that their drugs have the biggest clinical impact.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

The Pharma Data

NOVEMBER 10, 2020

By employing the services of a CV, the company has access to a fully-managed and outfitted animal research facility that includes supporting services for preclinical rodent research, which gives them complete control over their studies and enables them to keep studies “in-house”. .

Marketing 52

Marketing In-Vivo Scientist Research 52

pharmaphorum

DECEMBER 1, 2022

3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Etienne De Braekeleer, Senior Research Scientist, AstraZeneca. Billion by 2028. Dr Manjunath Hegde, Scientific Investigator & Associate Fellow, GSK.

In-Vitro 52

In-Vitro Scientist Engineer Gene Therapy 52

pharmaphorum

OCTOBER 11, 2022

Tunnah began his career as a scientist, studying biochemistry right through to PhD at the University of Oxford, his work at that time concerning very early stage, novel anti-cancer therapies (or ‘structural biophysics’). This] enabled people to access that in a way they hadn’t done before. And, actually, the answer in most cases is no.

Medicine 98

Medicine Pharma Companies Doctor Doctors 98

pharmaphorum

JANUARY 24, 2023

Rather than be provided a therapy that has been tested across a broad range of the population, there are now many therapies on the market that are designed specifically to work for sub-populations within disease areas. Scientists are able to study the aggregated, de-identified genetics of these individuals.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

pharmaphorum

FEBRUARY 11, 2022

This technology can be particularly beneficial for rare disease organisations as they often don’t have data scientists at their disposal or full-stack engineers. During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. ” About the interviewee.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. Reites comments that “our partnership strategy is to align with companies that have an equal view of the market. Novel digital endpoints. About the author.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

Cloudbyz

MAY 19, 2021

The gene therapy market reported its first market approvals back in 2017 and the evolution has been extensive ever since. Speaking of value growth, the global cell and gene therapy (CGT) market reached a value of nearly $4.39 The US and Canada are the major contributors to the cell and gene therapy market in North America.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Pharmaceutical Technology

DECEMBER 6, 2022

Using MEDELPHARM’s unique compaction simulation machines, scientists can produce prototypes of tablets at the same compression speeds of their industrial rotary press. Most importantly, the machines themselves are highly user friendly – something which has been appreciated by pharma companies and university laboratories around the world.

Containment 130

Containment Development Drugs Contract Manufacturing 130

World of DTC Marketing

NOVEMBER 24, 2020

According to STAT News “the spread of information — and misinformation — has been playing a crucial role throughout the unfolding coronavirus outbreak and should serve as a wake-up call for scientists who model epidemics. 2wo : Pharma websites are seen as a sales tool rather than a patient tool.

Scientist 277

Scientist Pharma Companies Production Sales 277

XTalks

MARCH 20, 2025

Find out the top pharma and biotech companies to work for in the US in 2025. Whether youre a scientist developing life-saving treatments, a regulatory expert ensuring drug safety or a business professional driving strategic growth, the right workplace makes a difference. billion, reflecting a remarkable 57.7% Merck & Co.

Sales 59

Sales Production Drugs Development 59

Pharmaceutical Technology

APRIL 17, 2023

But, following negative Phase III efficacy results, Lilly withdrew the drug from the market. If the Australian pharma company can demonstrate a renewed potential for the drug, Lilly could receive up to $255m in commercial and regulatory milestone payments. After this, Telix licenced the drug for $5m.

Development 130

Development Antibody Pharma Companies Licensing 130

pharmaphorum

NOVEMBER 19, 2020

By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.

Compliance 95

Compliance Marketing Sales Development 95

World of DTC Marketing

NOVEMBER 3, 2020

A prestigious team of medical scientists has projected that by 2030, nearly one in two adults will be obese, and nearly one in four will be severely obese. Pharma companies should be required to add content for health conditions that can be prevented by eating right and exercising. Employers also bear some responsibility.

Pharma Companies 190

Pharma Companies Scientist Medicine Research 190

XTalks

OCTOBER 22, 2020

The information shared between different multidisciplinary teams is critical to reducing the cost and ultimately accelerating the path of bringing a drug to market. To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

DECEMBER 29, 2022

Digital transformation has many different aspects, of course, but it is possible to pick out the most important ways technology and automation can support pharma companies to mitigate increased complexity and help respond fast to challenges and opportunities in the years ahead. Crisis readiness and digital workflows.

Manufacturing 111

Manufacturing Medicine Pharma Companies Engineer 111

pharmaphorum

FEBRUARY 14, 2022

In particular, the cost to bring an asset to market has declined successively from 2019 to 2021, with the cost to launch being reduced from $2.43 According to Deloitte, this can be attributed to the increase in the number of assets in the late stage pipeline of the companies studied, which saw an average of 16.1 billion to $2 billion.

Production 98

Production Clinical Trials Clinical Trials Sales 98

XTalks

AUGUST 18, 2020

Today’s authorization is another example of the FDA working with test developers to bring the most innovative technology to market in an effort to ensure access to testing for all people in America.”. At the time, office officials and sports scientists in the NBA were hunting for possible testing options that were fast, cheap and accessible.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Delveinsight

DECEMBER 15, 2020

The FTA designation will help the pharma company to advance its research and development in the NASH landscape and help its commercialization in the market. The present NASH treatment market is dominated and supported by off-label therapies. Welcome the new entrant in Gene therapy market: InnoSkel.

Vaccination 54

Vaccination Vaccine Gene Therapy Gene 54

pharmaphorum

MARCH 9, 2021

Regeneron and Eli Lilly have already got antibody therapies on the market following emergency approvals by regulators including the FDA but pharma companies are beginning to focus on the threat posed by emerging variants.

Antibody 98

Antibody Life Science Scientist Development 98

World of DTC Marketing

JANUARY 28, 2021

At first thought, people might be thanking pharma companies for developing COVID-19 vaccines and they would be partly right. The truth is that these companies are going to make billions of dollars. struggling during the pandemic, it’s health insurance companies that are thriving. Please read that again.

Vaccination 180

Vaccination Vaccine Manufacturing Scientist 180

pharmaphorum

OCTOBER 5, 2020

The 68-year-old – credited with being a catalyst for Merck’s highly lucrative move into cancer immunotherapy – will officially retire from the big pharma company at the end of the year. He will be succeeded by Dean Li, who is currently Merck’s senior vice president of discovery sciences and translational medicine.

Sales 52

Sales Medicine FDA Approval Vaccine 52

pharmaphorum

APRIL 19, 2021

It is really important and we have seen a lot of pharma companies interested in the UK. Amid all the positive developments from the UK in terms of its research response to the COVID crisis, Dix said that the longer-term consequence of the pandemic will be to reverse a trend that has seen many pharma companies opt to leave the country.

Vaccination 98

Vaccination Vaccine Life Science Antibody 98

pharmaphorum

DECEMBER 21, 2020

The launch raised $500m from investors using what is arguably the slickest stock market ticker out there – MRNA. They are very good doctors, scientists and entrepreneurs. He told pharmaphorum: “They are very good doctors, scientists and entrepreneurs. I was intrigued by the personalities of the founders.

Vaccination 111

Vaccination Vaccine Doctor Doctors 111

pharmaphorum

DECEMBER 2, 2020

. “The ‘first industrial war’ involved drug producers as much as weapons manufacturers” Erhart died in 1891, and Pfizer in 1906, leaving a company of around 200 employees in the hands of Emil Pfizer, who served as president until the 1940s, the last member of the Pfizer family to be involved in managing the company.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

World of DTC Marketing

NOVEMBER 30, 2020

-As Pfizer pharmaceutical breaks news for bringing Covid-19 vaccine, a former vice president and Chief Scientist of the company Michael Yeadon said that there is no need for any vaccine to end the ongoing pandemic.

Vaccine 210

Vaccine Vaccination Scientist Pharma Companies 210